Biolligence

Biolligence is a biotechnology company developing AI-ready toxicity datasets and predictive tools for the drug discovery industry.

The company combines deep learning algorithms with stem cell-derived in vitro models and clinical data to generate mechanistic toxicity information aimed at reducing dependence on animal testing in preclinical development.

Its platform targets pharma, biotech, and CRO clients seeking earlier and more human-relevant safety assessment.